UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Journal of Neurology, 2016-08, Vol.263 (8), p.1473-1494

2016

Volltextzugriff (PDF)

Therapies for multiple sclerosis: translational achievements and outstanding needs

Trends in molecular medicine, 2013-05, Vol.19 (5), p.309-319

2013

Volltextzugriff (PDF)

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

Annals of neurology, 2014-12, Vol.76 (6), p.792-801

2014

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Volltextzugriff (PDF)

Bioactivity and properties of a dental adhesive functionalized with polyhedral oligomeric silsesquioxanes (POSS) and bioactive glass

Dental materials, 2017-09, Vol.33 (9), p.1056-1065

2017

Volltextzugriff (PDF)

Safety and Efficacy of an Inhaled Epidermal Growth Factor Receptor Inhibitor (BIBW 2948 BS) in Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2010-03, Vol.181 (5), p.438-445

2010

Volltextzugriff (PDF)

The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts

The European respiratory journal, 2015-11, Vol.46 (5), p.1322-1333

2015

Volltextzugriff (PDF)

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF

Multiple sclerosis, 2015-07, Vol.21 (8), p.1036-1044

2015

Volltextzugriff (PDF)

PML risk stratification using anti-JCV antibody index and L-selectin

Multiple sclerosis, 2016-07, Vol.22 (8), p.1048-1060

2016

Volltextzugriff (PDF)

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

Journal of neurology, 2013-05, Vol.260 (5), p.1382-1387

2013

Volltextzugriff (PDF)

Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice

Respiratory research, 2005-11, Vol.6 (1), p.139-139, Article 139

2005

Volltextzugriff (PDF)

Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein

Brain (London, England : 1878), 1999-11, Vol.122 (11), p.2089-2100

1999

Volltextzugriff (PDF)

Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis

Annals of neurology, 2011-09, Vol.70 (3), p.520-520

2011

Volltextzugriff (PDF)

Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod

Multiple sclerosis, 2014-11, Vol.20 (13), p.1714-1720

2014

Volltextzugriff (PDF)

Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma

American journal of respiratory and critical care medicine, 2004-03, Vol.169 (5), p.578-586

2004

Volltextzugriff (PDF)

In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalization

Experimental cell research, 2011, Vol.317 (1), p.42-50

2011

Volltextzugriff (PDF)

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies

Archives of neurology (Chicago), 2007-09, Vol.64 (9), p.1331

2007

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Therapies for multiple sclerosis: translational achievements and outstanding needs

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Bioactivity and properties of a dental adhesive functionalized with polyhedral oligomeric silsesquioxanes (POSS) and bioactive glass

Safety and Efficacy of an Inhaled Epidermal Growth Factor Receptor Inhibitor (BIBW 2948 BS) in Chronic Obstructive Pulmonary Disease

The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts

Association of smoking but not HLA-DRB115:01, APOE or body mass index with brain atrophy in early multiple sclerosis

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF

PML risk stratification using anti-JCV antibody index and L-selectin

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice

Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein

Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis

Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod

Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma

In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalization

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies

Aktive Filter

Suchergebnisse filtern